Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

American Heart Journal

Volumn 160, Issue 3, 2010, Pages 428-434

  Traverse, Jay H ^a,b   McKenna, David H ^b,c   Harvey, Karen ^a   Jorgenso, Beth C ^a   Olson, Rachel E ^a   Bostrom, Nancy ^c   Kadidlo, Diane ^c   Lesser, John R ^a,b   Jagadeesan, Vikrant ^a   Garberich, Ross ^a   Henry, Timothy D ^a,b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ANGIOPLASTY; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CARDIAC MAGNETIC RESONANCE IMAGING; CARDIAC PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORONARY STENT; DOUBLE BLIND PROCEDURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART PALPITATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNCOPE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; ADULT; AGED; COMPLICATION; ETIOLOGY; HEART STROKE VOLUME; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PROCEDURES; STEM CELL TRANSPLANTATION; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STENTS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 77956364230     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.009     Document Type: Article

References (26)

1. Strauer B.E., Brehm M., and Zeus T. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
2. Orlic D., Kajstura J., and Chimenti S. Bone marrow cells regenerate infracted myocardium Nature 410 2001 701 705
3. Schächinger V., Erbs S., and Elsässer A. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 2006 1210 1221
4. Wollert K.C., Meyer G.P., and Lotz J. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial Lancet 364 2004 141 148
5. Lunde K., Solheim S., and Aakhus S. Intracoronary injection of mononuclear bone marrow cells in acute wall infarction N Engl J Med 355 2006 1199 1209
6. Janssens S., Dubois C., and Bogaert J. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 2006 113 121
7. Abdel-Latif A., Bolli R., and Tleyjeh I.M. Adult bone marrow-derived cells for cardiac repair: a systemic review and meta-analysis Arch Int Med 167 2007 989 997
8. Lipinski M.J., Biondi-Zoccai G.G.L., and Abbate A. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction JACC 50 2007 1761 1767
9. Martin-Rendon E., Brunskill S.J., and Hyde C.J. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review Eur Heart J 29 2008 1807 1818
10. Seeger F.H., Tonn T., and Krzossok N. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction Eur Heart J 28 2007 766 772
11. Ii M., Nishimura H., and Iwakura A. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity Circulation 111 2005 1114
12. Traverse J.H., Henry T.D., and Vaughan D.E. Rationale and design for TIME: a phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction Am Heart J 158 2009 356 363
13. Schachinger V., Erbs S., and Elsasser A. Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial Eur Heart J 27 2006 2775 2783
14. Meyer G.P., Wollert K.C., and Lotz J. Intracoronary bone marrow cell transfer after myocardial infarction: 18 months' follow-up data from randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 2006 1287 1294
15. Herbots L., D'hooge J., and Eroglu E. Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study Eur Heart J 30 2009 662 670
16. 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction J Nucl Med 48 2007 1708 1714
17. Meluzin J., Vlasin M., and Groch L. Intracoronary delivery of bone marrow cells to the acutely infracted myocardium. Optimization of the delivery technique Cardiology 112 2009 98 106
18. Tossios P., Krausgrill B., and Schmidt M. Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction Eur Heart J 29 2008 1911 1921
19. Kamota T., Li T.S., and Morikage N. Ischemic pre-conditioning enhances mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase JACC 19 2009 1814 1822
20. Engblom H., Hedstrom E., and Heiberg E. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone. One-year follow-up by MRI Circ Cardiovasc Imaging 2 2009 47 55
21. Ottani F., Galli M., and Zerboni S. Prodromal angina limits infarct size in the setting of acute myocardial infarction treated with primary percutaneous intervention JACC 45 2005 1545 1547
22. Kloner R.A., Shook T., and Przyklenk K. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 91 1995 37 45
23. Tissier R., Couvreur N., and Ghaleh B. Rapid cooling preserves the ischaemic myocardium against mitochondrial damage and left-ventricular dysfunction Cardiovasc Res 83 2009 345 353
24. Lonborg J., Kelbaek H., and Vejlstrup N. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous intervention, evaluated by magnetic resonance Circ Cardiovasc Interv 3 2010 34 41
25. Traverse J.H., Wang Y.L., and Chavez I.J. Post-conditioning reduces infarct size and improves LV function during acute myocardial infarction Circulation 114 2006 II 344
26. Sardella G., Mancone M., and Bucciarelli-Ducci C. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial J Am Coll Cardiol 53 2009 309 315